Quince Therapeutics, Inc. (QNCX)
NASDAQ: QNCX · Real-Time Price · USD
1.860
-0.070 (-3.63%)
At close: Oct 17, 2025, 4:00 PM EDT
1.600
-0.260 (-13.98%)
After-hours: Oct 17, 2025, 7:59 PM EDT
Quince Therapeutics Market Cap
Quince Therapeutics has a market cap or net worth of $99.91 million as of October 17, 2025. Its market cap has increased by 197.88% in one year.
Market Cap
99.91M
Enterprise Value
82.69M
1-Year Change
197.88%
Ranking
Category
Stock Price
$1.86
Market Cap Chart
Since May 9, 2019, Quince Therapeutics's market cap has decreased from $855.58M to $99.91M, a decrease of -88.32%. That is a compound annual growth rate of -28.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 99.91M | 21.42% |
| Dec 31, 2024 | 82.28M | 82.80% |
| Dec 29, 2023 | 45.01M | 95.46% |
| Dec 30, 2022 | 23.03M | -93.89% |
| Dec 31, 2021 | 377.06M | -53.99% |
| Dec 31, 2020 | 819.45M | -45.64% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 720.73B |
| Johnson & Johnson | 465.34B |
| AbbVie | 405.55B |
| UnitedHealth Group | 322.96B |
| AstraZeneca | 260.83B |
| Novartis AG | 254.64B |
| Novo Nordisk | 237.72B |
| Abbott Laboratories | 223.72B |